Applied Therapeutics, Inc. Made Headway
Applied Therapeutics, Inc. (APLT:NASDAQ) soared at $1.8, a gain of 42.9%. On Wed, Sep 06, 2023, APLT:NASDAQ hit a New 2-Week High of $1.8. The stock got featured on our News Catalysts scanner on Wed, Sep 06, 2023 at 01:29 PM in the 'ACQUISITION' category. From Wed, Aug 23, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Aug 02, 2023 at $2.18 with a volume of 1M+.
About Applied Therapeutics, Inc. (APLT:NASDAQ)
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 108.73%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 106.96%
- Power REIT (PW:NYSEMKT), 55.12%
- Theratechnologies Inc. (THTX:NASDAQ), 47.57%
- Marin Software Incorporated (MRIN:NASDAQ), 45.49%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 42.86%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 30.26%
- FLJ Group Limited (FLJ:NASDAQ), 28.24%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 26.07%
- Signature Bank (SBNY:NASDAQ), 25%